Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K FOTHERBY

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Contraception|May 1, 1990
Potency and pharmacokinetics of gestagensK Fotherby
Contraception|April 1, 1985
Oral contraceptives, lipids and cardiovascular diseaseK Fotherby
American Journal of Obstetrics and Gynecology|July 1, 1990
Pharmacokinetics of gestagens: some problemsK Fotherby
Journal of Steroid Biochemistry|July 1, 1983
Variability of pharmacokinetic parameters for contraceptive steroidsK Fotherby
Contraception|November 1, 1992
Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms oestrogenK Fotherby
Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception|March 1, 1986
Effect of oral contraceptives on serum apoprotein levelsK Fotherby
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1991
Intrasubject variability in the pharmacokinetics of ethynyloestradiolK Fotherby
Contraception|June 9, 1998
Metabolic interrelationships, cardiovascular disease, and sex steroidsK Fotherby
Contraception|August 1, 1996
Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapyK Fotherby
Contraception|January 1, 1995
Twelve years of clinical experience with an oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrelK Fotherby
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Contraception|May 1, 1990
Potency and pharmacokinetics of gestagensK Fotherby
Contraception|April 1, 1985
Oral contraceptives, lipids and cardiovascular diseaseK Fotherby
American Journal of Obstetrics and Gynecology|July 1, 1990
Pharmacokinetics of gestagens: some problemsK Fotherby
Journal of Steroid Biochemistry|July 1, 1983
Variability of pharmacokinetic parameters for contraceptive steroidsK Fotherby
Contraception|November 1, 1992
Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms oestrogenK Fotherby
Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception|March 1, 1986
Effect of oral contraceptives on serum apoprotein levelsK Fotherby
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1991
Intrasubject variability in the pharmacokinetics of ethynyloestradiolK Fotherby
Contraception|June 9, 1998
Metabolic interrelationships, cardiovascular disease, and sex steroidsK Fotherby
Contraception|August 1, 1996
Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapyK Fotherby
Contraception|January 1, 1995
Twelve years of clinical experience with an oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrelK Fotherby
Pageof 7